Home
>
National Drug Code (NDC)
>
Depakote
Depakote - 0074-3826-13 - (Divalproex Sodium)
Drug Information of Depakote
| Product NDC: | 0074-3826 |
| Proprietary Name: | Depakote |
| Non Proprietary Name: | Divalproex Sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; Divalproex Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Depakote
| Product NDC: | 0074-3826 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021168 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20000804 |
Package Information of Depakote
| Package NDC: | 0074-3826-13 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3826-13) |
NDC Information of Depakote
| NDC Code | 0074-3826-13 |
| Proprietary Name | Depakote |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0074-3826-13) |
| Product NDC | 0074-3826 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Divalproex Sodium |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20000804 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | DIVALPROEX SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
